US5547936A
(en)
*
|
1985-06-17 |
1996-08-20 |
La Jolla Cancer Research Foundation |
Inhibition of cell migration with synthetic peptides
|
US5827821A
(en)
*
|
1987-12-10 |
1998-10-27 |
The Burnham Institute |
Conformationally stabilized cell adhesion peptides
|
JP2547263B2
(ja)
*
|
1987-12-10 |
1996-10-23 |
ラ・ジョラ・キャンサー・リサーチ・ファウンデーション |
立体配座的に安定化された細胞付着ペプチド
|
CA1324954C
(en)
*
|
1988-03-10 |
1993-12-07 |
Erkki I. Ruoslahti |
Inhibition of cell migration with synthetic peptides
|
ZW6189A1
(en)
*
|
1988-05-09 |
1990-05-09 |
Smithkline Beckman Corp |
Anti-aggregatory peptides
|
US5037808A
(en)
*
|
1988-07-20 |
1991-08-06 |
Monsanto Co. |
Indolyl platelet-aggregation inhibitors
|
WO1990005103A1
(en)
*
|
1988-11-03 |
1990-05-17 |
Prime Technology |
A sheet feeding apparatus
|
DE3841753A1
(de)
*
|
1988-12-12 |
1990-06-13 |
Basf Ag |
Neue tnf-peptide
|
CA2008116C
(en)
*
|
1989-02-23 |
2001-11-20 |
Thomas Weller |
Glycine derivatives
|
US5795867A
(en)
*
|
1989-06-16 |
1998-08-18 |
Cor Therapeutics, Inc. |
Platelet aggregation inhibitors
|
US5686568A
(en)
*
|
1989-06-16 |
1997-11-11 |
Cor Therapeutics, Inc. |
Platelet aggregration inhibitors
|
US5395609A
(en)
*
|
1989-06-19 |
1995-03-07 |
Antisoma Limited |
Synthetic peptides for use in tumor detection
|
GB8914020D0
(en)
†
|
1989-06-19 |
1989-08-09 |
Antisoma Ltd |
Synthetic peptides for use in thrombus detection
|
US5061693A
(en)
*
|
1989-07-28 |
1991-10-29 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
CA2021952A1
(en)
*
|
1989-07-28 |
1991-01-29 |
Ruth F. Nutt |
Fibrinogen receptor antagonists
|
US5023233A
(en)
*
|
1989-07-28 |
1991-06-11 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
EP0410540A1
(en)
*
|
1989-07-28 |
1991-01-30 |
Merck & Co. Inc. |
Fibrinogen receptor antagonists
|
EP0410541A1
(en)
*
|
1989-07-28 |
1991-01-30 |
Merck & Co. Inc. |
Fibrinogen receptor antagonists
|
US5338723A
(en)
*
|
1989-10-13 |
1994-08-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
NZ235564A
(en)
*
|
1989-10-13 |
1993-10-26 |
Merck & Co Inc |
Fibrinogen receptor antagonist and pharmaceutical compositions
|
NZ235563A
(en)
*
|
1989-10-13 |
1993-04-28 |
Merck & Co Inc |
Fibrinogen receptor antagonist and pharmaceutical composition
|
US5643872A
(en)
*
|
1989-10-23 |
1997-07-01 |
Smithkline Beecham Corporation |
Cyclic anti-aggregatory peptides
|
AU6470590A
(en)
*
|
1989-10-23 |
1991-04-26 |
Smithkline Beecham Corporation |
Cyclic anti-aggregatory peptides
|
WO1991007429A1
(en)
*
|
1989-11-09 |
1991-05-30 |
Smithkline Beecham Corporation |
Anti-aggregatory peptides containing a mercaptan or sulfide moiety
|
US5273982A
(en)
*
|
1990-03-09 |
1993-12-28 |
Hoffmann-La Roche Inc. |
Acetic acid derivatives
|
GB9007751D0
(en)
*
|
1990-04-05 |
1990-06-06 |
Ciba Geigy Ag |
Novel platelet-aggregation inhibitors
|
DK0527798T3
(da)
*
|
1990-04-06 |
1997-12-15 |
Jolla Cancer Res Found |
Fremgangsmåde og sammensætning til behandling af thrombose
|
US5672585A
(en)
*
|
1990-04-06 |
1997-09-30 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US5648330A
(en)
*
|
1990-04-06 |
1997-07-15 |
La Jolla Cancer Research Foundation |
Method and composition for treating vascular graft occlusion
|
US6017877A
(en)
*
|
1990-04-06 |
2000-01-25 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US5780303A
(en)
*
|
1990-04-06 |
1998-07-14 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US6521594B1
(en)
|
1990-04-06 |
2003-02-18 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US5612311A
(en)
|
1990-04-06 |
1997-03-18 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
DE69200766T2
(de)
*
|
1991-03-06 |
1995-05-04 |
G.D. Searle & Co., Chicago, Ill. |
Phenylamidinderivate als plättchenaggregationsinhibitoren.
|
WO1992017492A1
(en)
*
|
1991-04-05 |
1992-10-15 |
Genentech, Inc. |
PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIII¿a?
|
US5220050A
(en)
*
|
1991-05-17 |
1993-06-15 |
G. D. Searle & Co. |
Peptide mimetic compounds useful as platelet aggregation inhibitors
|
US5939412A
(en)
*
|
1992-06-26 |
1999-08-17 |
Smithkline Beecham Corporation |
Bicyclic fibrinogen antagonists
|
PT100631B
(pt)
*
|
1991-06-28 |
1999-06-30 |
Smithkline Beecham Corp |
Antagonistas biciclicos de fibrinogenio, seu uso e composicoes farmaceuticas que os contem
|
US5625093A
(en)
*
|
1991-10-15 |
1997-04-29 |
G. D. Searle & Co. |
Substituted β-amino acid derivatives useful as platelet aggregation inhibitors
|
US5239113A
(en)
*
|
1991-10-15 |
1993-08-24 |
Monsanto Company |
Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
|
DE69229004D1
(de)
*
|
1991-11-07 |
1999-05-27 |
Univ Southern California |
Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung
|
WO1993012103A1
(en)
*
|
1991-12-13 |
1993-06-24 |
G.D. Searle & Co. |
Phenyl amidines lactones useful as platelet aggregation inhibitors
|
US5424334A
(en)
*
|
1991-12-19 |
1995-06-13 |
G. D. Searle & Co. |
Peptide mimetic compounds useful as platelet aggregation inhibitors
|
US5264457A
(en)
*
|
1992-02-14 |
1993-11-23 |
G. D. Searle & Co. |
Phenyl amidines sulfonamides useful as platelet aggregation inhibitors
|
CA2131367A1
(en)
*
|
1992-03-04 |
1993-09-16 |
Sandor Bajusz |
New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
|
JP3274225B2
(ja)
|
1992-06-03 |
2002-04-15 |
富士写真フイルム株式会社 |
アミノ酸誘導体及びその用途
|
US5504106A
(en)
*
|
1992-06-25 |
1996-04-02 |
G. D. Searle & Co. |
Phenyl amidine alkanoic acids and lactones useful as platelet aggregation inhibitors
|
FR2692899B1
(fr)
*
|
1992-06-30 |
1994-08-19 |
Adir |
Nouveaux dérivés peptidiques actifs dans les processus d'adhésion cellulaire, leur procédé de préparation et les compositions pharmaceutiques qui les renferment.
|
JPH06192291A
(ja)
*
|
1992-09-07 |
1994-07-12 |
Nippon Steel Corp |
新規ペプチドとそれを用いた血小板凝集抑制剤及び血液凝固抑制剤
|
US6380163B1
(en)
*
|
1992-12-22 |
2002-04-30 |
Baxter International Inc. |
Peritoneal dialysis solutions with polypeptides
|
US5409939A
(en)
*
|
1993-02-12 |
1995-04-25 |
G. D. Searle & Co. |
Phenyl amidine thio derivatives useful as platelet aggregation inhibitors
|
GB9312315D0
(en)
*
|
1993-06-15 |
1993-07-28 |
Poston Robin |
Leukocyte adhesion assay
|
US5612355A
(en)
*
|
1993-06-23 |
1997-03-18 |
G. D. Searle & Co. |
Phenyl amidine lactones useful as platelet aggregation inhibitors
|
MA23420A1
(fr)
*
|
1994-01-07 |
1995-10-01 |
Smithkline Beecham Corp |
Antagonistes bicycliques de fibrinogene.
|
US6458784B1
(en)
|
1994-06-29 |
2002-10-01 |
Smithkline Beecham Corporation |
Vitronectin receptor antagonists
|
US6387880B1
(en)
|
1994-10-24 |
2002-05-14 |
G.D. Searle & Co. |
Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L-α-aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts
|
US5677276A
(en)
*
|
1994-12-23 |
1997-10-14 |
La Jolla Cancer Research Foundation |
Immobilization of peptides to hyaluronate
|
US5977101A
(en)
*
|
1995-06-29 |
1999-11-02 |
Smithkline Beecham Corporation |
Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
|
IL129877A
(en)
*
|
1996-11-27 |
2004-08-31 |
Aventis Pharm Prod Inc |
A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
|
US5872122A
(en)
*
|
1997-10-16 |
1999-02-16 |
Monsanto Company |
Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation
|
AU736951C
(en)
|
1998-03-19 |
2003-02-20 |
Bristol-Myers Squibb Company |
Biphasic controlled release delivery system for high solubility pharmaceuticals and method
|
US6037365A
(en)
*
|
1998-09-25 |
2000-03-14 |
G.D. Searle & Co. |
Aminobenzamidinosuccinyl lactone derivatives useful as inhibitors of platelet aggregation
|
CN1809590A
(zh)
*
|
2003-04-22 |
2006-07-26 |
阿文尼尔药品公司 |
治疗高胆固醇血症的反向胆固醇转动的介质
|
US20050159362A1
(en)
*
|
2003-04-22 |
2005-07-21 |
Sircar Jagadish C. |
Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
|
WO2007055873A2
(en)
*
|
2005-11-04 |
2007-05-18 |
Avanir Pharmaceuticals |
Process for the manufacture of peptide facilitators of reverse cholesterol transport
|
JP6042330B2
(ja)
|
2010-07-09 |
2016-12-14 |
ビーエイチヴィ ファーマ、インコーポレイテッド |
レモグリフロジンを含めた半減期が短い医薬品のための組合せ即時/遅延放出送達システム
|
WO2015103643A2
(en)
*
|
2014-01-06 |
2015-07-09 |
The General Hospital Corporation |
Integrin antagonists
|
CN112430254B
(zh)
*
|
2020-11-25 |
2021-10-26 |
广东海洋大学 |
一种抗凝血活性肽衍生物及其制备方法和用途
|